State of Alaska Department of Revenue Sells 82 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

State of Alaska Department of Revenue decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 0.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,856 shares of the medical instruments supplier’s stock after selling 82 shares during the period. State of Alaska Department of Revenue owned about 0.06% of ICU Medical worth $2,150,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of ICUI. Allworth Financial LP boosted its stake in shares of ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 100 shares during the last quarter. Venturi Wealth Management LLC lifted its position in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 302 shares in the last quarter. Point72 Hong Kong Ltd purchased a new position in ICU Medical during the third quarter valued at $72,000. GAMMA Investing LLC lifted its position in ICU Medical by 83.6% during the third quarter. GAMMA Investing LLC now owns 571 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares in the last quarter. Finally, Greenleaf Trust purchased a new position in ICU Medical during the third quarter valued at $207,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Price Performance

Shares of ICU Medical stock opened at $159.78 on Tuesday. The stock’s 50-day simple moving average is $160.70 and its 200-day simple moving average is $164.00. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The company has a market capitalization of $3.91 billion, a price-to-earnings ratio of -34.96 and a beta of 0.63. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Insider Activity

In other news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $17,039,245.63. The trade was a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 17,737 shares of company stock worth $2,879,752 over the last ninety days. Corporate insiders own 6.70% of the company’s stock.

Analyst Ratings Changes

ICUI has been the topic of several analyst reports. KeyCorp lifted their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $199.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.